75 filings
Page 3 of 4
8-K
dv48vc
4 Aug 20
Departure of Directors or Certain Officers
4:16pm
8-K
hznnb5c7aqxp7l vncp
11 May 20
Amneal Reports First Quarter 2020 Financial Results
6:47am
8-K
1o7k4x
8 May 20
Departure of Directors or Certain Officers
7:43am
8-K/A
o87faaw6n 1kv
17 Apr 20
Independent Auditor’s Report
4:05pm
8-K
iaauqjpv6mvs
12 Mar 20
Amneal Pharmaceuticals Appoints Tasos Konidaris as Senior Vice President, Chief Financial Officer
5:19pm
8-K
u6kz9vukpqw3ygirc
26 Feb 20
Departure of Directors or Certain Officers
4:55pm
8-K
w385p0ffmz3fjj
26 Feb 20
Amneal Reports Fourth Quarter and Full Year 2019 Financial Results
6:50am
8-K/A
dy8kp wxy
20 Feb 20
Departure of Directors or Certain Officers
4:49pm
8-K/A
vwbspli
20 Feb 20
Departure of Directors or Certain Officers
4:47pm
8-K
e0n8zb kprgyauieuj
4 Feb 20
Entry into a Material Definitive Agreement
12:00am
8-K
b7av52ubc3i7j
15 Jan 20
Regulation FD Disclosure
10:32am
8-K
vfl4m14y1u9 23o
16 Dec 19
Amneal Appoints Jeff George, John Kiely and Shlomo Yanai to Board of Directors
4:50pm
8-K
zzqfd5tkp 134cu
10 Dec 19
Amneal to Acquire Majority Interest in AvKARE, Enhancing Access
4:51pm
8-K
hty f3ns463be2y2d
6 Nov 19
Amneal Reports Third Quarter 2019 Financial Results
6:54am
8-K
wr3q87
11 Oct 19
Submission of Matters to a Vote of Security Holders
12:07pm
8-K
aev5ehs1ewl6u42x
5 Aug 19
Amneal Reports Second Quarter 2019 Financial Results
6:20am
8-K
gcmasil69a pi
5 Aug 19
Paul Meister Elected Chairman of the Board
6:13am
8-K
rnisn0mzlrh
10 Jul 19
Amneal Pharmaceuticals Announces Restructuring and Costs Savings Plan to Improve Operations and Position the Company for Future Growth
4:52pm
8-K
l2au7z
9 May 19
Departure of Directors or Certain Officers
4:43pm
8-K
qmh6p
9 May 19
Amneal Reports First Quarter 2019 Financial Results
6:42am